Moshe Sade-Feldman

12.0k total citations
32 papers, 1.3k citations indexed

About

Moshe Sade-Feldman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Moshe Sade-Feldman has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 19 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Moshe Sade-Feldman's work include Cancer Immunotherapy and Biomarkers (13 papers), Immune cells in cancer (10 papers) and Immunotherapy and Immune Responses (7 papers). Moshe Sade-Feldman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immune cells in cancer (10 papers) and Immunotherapy and Immune Responses (7 papers). Moshe Sade-Feldman collaborates with scholars based in United States, Israel and Austria. Moshe Sade-Feldman's co-authors include Michal Baniyash, Julia Kanterman, Eliran Ish‐Shalom, Mazal Elnekave, E. Philip Horwitz, Yair Klieger, Olga Mizrahi, Michal Lotem, Amijai Saragovi and Audrey Lasry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Moshe Sade-Feldman

28 papers receiving 1.3k citations

Peers

Countries citing papers authored by Moshe Sade-Feldman

Since Specialization

Citations

This map shows the geographic impact of Moshe Sade-Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Sade-Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Sade-Feldman more than expected).

Fields of papers citing papers by Moshe Sade-Feldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Sade-Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Sade-Feldman. The network helps show where Moshe Sade-Feldman may publish in the future.

Co-authorship network of co-authors of Moshe Sade-Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Sade-Feldman. A scholar is included among the top collaborators of Moshe Sade-Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Sade-Feldman. Moshe Sade-Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling alternative splicing dynamics in activated T lymphocytes and their implications for immune checkpoint blockade efficacy 2025 ·iScience ·(unknown), Otto Stern, (unknown), (unknown), Thomas Eisenhaure, Sarah E. Henrickson, Moshe Sade-Feldman, (unknown), Galit Eisenberg, Nir Hacohen, Keren Yizhak, Michal Lotem	0
2	Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma 2025 ·OncoImmunology ·(unknown), Michael Bryan, (unknown), Ross D. Merkin, (unknown), Thomas J. Roberts, Manisha J. Patel, Jong Chul Park, Lori J. Wirth, Peter M. Sadow, Moshe Sade-Feldman, Shannon L. Stott, Daniel L. Faden	1
3	Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade 2024 ·Frontiers in Immunology ·(unknown), Jillian F. Wise, (unknown), João Paulo Oliveira–Costa, (unknown), Peter M. Sadow, Jacy Fang, Osman Yılmaz, (unknown), (unknown), Moshe Sade-Feldman, Daniel L. Faden, Shannon L. Stott	1
4	A latent Axin2+/Scx+ progenitor pool is the central organizer of tendon healing 2024 ·npj Regenerative Medicine ·Mor Grinstein, Stephanie Tsai, Daniel T. Montoro, Benjamin R. Freedman, Heather L. Dingwall, (unknown), (unknown), Moshe Sade-Feldman, Miho J. Tanaka, David Mooney, Terence D. Capellini, Jayaraj Rajagopal, Jenna L. Galloway	4
5	Characterizing the tumor and immune landscape of patients with melanoma treated with combined checkpoint blockade and MAPK-targeted therapy. 2024 ·Journal of Clinical Oncology ·(unknown), Irena Gushterova, Thomas J. LaSalle, Emily M. Blaum, Tatyana Sharova, (unknown), Anita Giobbie‐Hurder, Moshe Sade-Feldman, Keren Yizhak, Nir Hacohen, Ryan J. Sullivan	1
6	Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 ⁺ T cell response 2024 ·Science Immunology ·Aleksey Chudnovskiy, Tiago B. R. Castro, Sandra Nakandakari-Higa, Ang Cui, Chia‐Hao Lin, Moshe Sade-Feldman, (unknown), Juhee Pae, Luka Mesin, Juliana Bortolatto, Lawrence D. Schweitzer, Giulia Pasqual, Li‐Fan Lu, Nir Hacohen, Gabriel D. Victora	9
7	Dissociation of Human and Mouse Tumor Tissue Samples for Single-cell RNA Sequencing 2024 ·Journal of Visualized Experiments ·Jacy Fang, (unknown), (unknown), (unknown), Moshe Sade-Feldman	0
8	Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in 365 Patients with MGUS and SMM Demonstrates Complex Progressive Changes in Immune Cell Functionality with a Distinct Footprint on Tumor Cell Biology and Disease Control 2024 ·Blood ·Romanos Sklavenitis‐Pistofidis, Ting Wu, Elizabeth D. Lightbody, (unknown), Mahshid Rahmat, Michael P. Agius, Junko Tsuji, Jean-Baptiste Alberge, (unknown), Ankit K. Dutta, (unknown), (unknown), (unknown), Nicholas J. Haradhvala, Moshe Sade-Feldman, Gad Getz, Irene M. Ghobrial	0
9	Impact of tertiary lymphoid structures in response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Ross D. Merkin, Thomas J. Roberts, Manisha J. Patel, Jong Chul Park, Lori J. Wirth, Peter M. Sadow, Moshe Sade-Feldman, Shannon L. Stott, Daniel L. Faden	1
10	High-throughput RNA isoform sequencing using programmed cDNA concatenation 2023 ·Nature Biotechnology ·Aziz Al’Khafaji, Jonathan T. Smith, Kiran Garimella, Mehrtash Babadi, Victoria Popic, Moshe Sade-Feldman, (unknown), Siranush Sarkizova, Marc A. Schwartz, Emily M. Blaum, (unknown), Maura Costello, Tera Bowers, Stacey Gabriel, Eric Banks, Anthony Philippakis, Genevieve M. Boland, Paul C. Blainey, Nir Hacohen	81
11	Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purity 2023 ·STAR Protocols ·Anna Gonye, Thomas J. LaSalle, Samuel S. Freeman, Miguel Reyes, Nir Hacohen, Alexandra–Chloé Villani, Moshe Sade-Feldman	4
12	The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia 2022 ·mBio ·Chuangqi Wang, Yijia Li, Paulina Kapłonek, Matteo Gentili, Stephanie Fischinger, Kathryn Bowman, Moshe Sade-Feldman, Kyle R. Kays, James Regan, James P. Flynn, Marcia B. Goldberg, Nir Hacohen, Michael R. Filbin, Douglas A. Lauffenburger, Galit Alter, Jonathan Z. Li	9
13	Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer 2022 ·Science Advances ·Marcello Stanzione, Jun Zhong, Edmond Wong, Thomas J. LaSalle, Jillian F. Wise, Antoine Simoneau, David T. Myers, Sarah Phat, Moshe Sade-Feldman, Michael S. Lawrence, M. Kyle Hadden, Lee Zou, Anna F. Farago, Nicholas J. Dyson, Benjamin J. Drapkin	22
14	Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children 2022 ·Cell Reports Medicine ·Brittany P. Boribong, Thomas J. LaSalle, Yannic C. Bartsch, Felix Ellett, Maggie Loiselle, Jameson P. Davis, Anna Gonye, David B. Sykes, Soroush Hajizadeh, Johannes Kreuzer, Shiv Pillai, Wilhelm Haas, Andrea G. Edlow, Alessio Fasano, Galit Alter, Daniel Irimia, Moshe Sade-Feldman, Lael M. Yonker	25
15	Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistance 2022 ·npj Precision Oncology ·Maoxuan Lin, Moshe Sade-Feldman, Lori J. Wirth, Michael S. Lawrence, Daniel L. Faden	7
16	Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions 2021 ·Cancer Immunology Research ·Emma Hajaj, (unknown), (unknown), Sharon Merims, Jonathan Cohen, Shiri Klein, Shoshana Frankenburg, Moshe Sade-Feldman, Yuval Tabach, Keren Yizhak, Ami Navon, Polina Stepensky, Nir Hacohen, Tamar Peretz, André Veillette, Rotem Karni, Galit Eisenberg, Michal Lotem	14
17	Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes 2014 ·Cancer Research ·Julia Kanterman, Moshe Sade-Feldman, Moshe Biton, Eliran Ish‐Shalom, Audrey Lasry, (unknown), Ayala Hubert, Michal Baniyash	139
18	Chronic inflammation and cancer: suppressing the suppressors 2013 ·Cancer Immunology Immunotherapy ·Michal Baniyash, Moshe Sade-Feldman, Julia Kanterman	89
19	New insights into chronic inflammation-induced immunosuppression 2012 ·Seminars in Cancer Biology ·Julia Kanterman, Moshe Sade-Feldman, Michal Baniyash	183
20	Cyclophosphamide Promotes Chronic Inflammation–Dependent Immunosuppression and Prevents Antitumor Response in Melanoma 2012 ·Journal of Investigative Dermatology ·Alexandra Sevko, Moshe Sade-Feldman, Julia Kanterman, Tillmann Michels, Christine S. Falk, Ludmila Umansky, (unknown), Masashi Kato, Dirk Schadendorf, Michal Baniyash, Viktor Umansky	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact